Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis
Bleeding is a relatively common issue in acute iTTP that has not been adequately addressed in existing literature. Further studies are needed to elucidate this risk and associated factors, especially given the incorporation of caplacizumab in the treatment of iTTP.
Authors
- Amir Mahmoud (ORCID: https://orcid.org/0000-0002-0630-1117)
- Mouhamed Yazan Abou‐Ismail (ORCID: https://orcid.org/0000-0002-6682-4366)
- Shruti Chaturvedi (ORCID: https://orcid.org/0000-0001-6832-2389)
- Mariam Mostafa (ORCID: https://orcid.org/0000-0002-3140-3991)
- Ali Abdelhay (ORCID: https://orcid.org/0000-0002-1277-9600)
Institutions
- Johns Hopkins University (US)
- Washington University in St. Louis (US)
- University of Utah (US)
- Johns Hopkins Medicine (US)
- Rochester General Hospital (US)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1016/j.rpth.2024.102654
- Citations
- 1
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.24
Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute